Literature DB >> 3089935

Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.

R A Eisenberg, J H Schwab.   

Abstract

The induction of acute arthritis in rats by a single intraperitoneal injection of group A streptococcal cell wall is associated with the activation of complement. We have therefore investigated the interaction of arthropathic peptidoglycan-polysaccharide complex of streptococcal cell walls and human complement. The incubation of cell wall in normal human serum results in the formation of complexes of cell wall and the C3 and C4 components of complement. Using agammaglobulinemic serum, we have further shown that the activation of complement and formation of complement-cell wall complexes absolutely requires the presence of a small quantity of specific antibody. This antibody is present in normal human immunoglobulin G and is effective as the Fab fragment (alternative pathway). Although antibodies specific for three cell wall epitopes were capable of inducing complement-cell wall complex formation by the classical complement pathway, only anti-A polysaccharide antibody (N-acetyl-D-glucosamine epitope) was effective by the alternative complement pathway. A complement consumption assay showed that anti-cell wall antibody was required not only for complement-cell wall complex formation, but also for activation of complement by streptococcal cell wall in human serum. These studies suggest that a minimal level of anti-cell wall antibody may be required for the induction of arthritis in rats by streptococcal cell wall.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089935      PMCID: PMC260878          DOI: 10.1128/iai.53.2.324-330.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Serum factors responsible for killing of Shigella.

Authors:  W P Reed; E L Albright
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

2.  Structure of the streptococcal groups A, A-variant and C carbohydrates.

Authors:  J E Coligan; T J Kindt; R M Krause
Journal:  Immunochemistry       Date:  1978-11

3.  Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.

Authors:  M S Edwards; D L Kasper; H J Jennings; C J Baker; A Nicholson-Weller
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

4.  In vivo changes in complement induced with peptidoglycan-polysaccharide polymers from streptococcal cell walls.

Authors:  J D Lambris; J B Allen; J H Schwab
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

5.  Antibody response to streptococcal cell wall antigens associated with experimental arthritis in rats.

Authors:  J J Greenblatt; N Hunter; J H Schwab
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

6.  Different functions for specific guinea pig IgG1 and IgG2 in the lysis of sheep erythrocytes by C4-deficient guinea pig serum.

Authors:  A Nicholson-Weller; M R Daha; K F Austen
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

7.  Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.

Authors:  D T Fearon; K F Austen
Journal:  N Engl J Med       Date:  1980-07-31       Impact factor: 91.245

8.  IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.

Authors:  F D Moore; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

9.  Determination of alternative pathway of complement activity in mouse serum using rabbit erythrocytes.

Authors:  H Van Dijk; P M Rademaker; J M Willers
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

10.  The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.

Authors:  M S Edwards; A Nicholson-Weller; C J Baker; D L Kasper
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  11 in total

1.  Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats.

Authors:  R B Sartor; S K Anderle; N Rifai; D A Goo; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

2.  Stimulation of complement component C3 synthesis in macrophagelike cell lines by group B streptococci.

Authors:  K J Goodrum
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

3.  Contrasting roles of mannan-specific monoclonal immunoglobulin M antibodies in the activation of classical and alternative pathways by Candida albicans.

Authors:  M X Zhang; J E Cutler; Y Han; T R Kozel
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

4.  Eicosanoid regulation of acute intestinal vascular permeability induced by intravenous peptidoglycan-polysaccharide polymers.

Authors:  C J Woolverton; J J White; R B Sartor
Journal:  Agents Actions       Date:  1989-03

Review 5.  Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.

Authors:  J H Schwab
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.

Authors:  Gayle M Boxx; Casey T Nishiya; Thomas R Kozel; Mason X Zhang
Journal:  Mol Immunol       Date:  2008-11-26       Impact factor: 4.407

7.  Sequential events in the pathogenesis of streptococcal cell wall-induced arthritis and their modulation by bis(5-amidino-2-benzimidazolyl)methane (BABIM).

Authors:  J D Geratz; R R Tidwell; J H Schwab; S K Anderle; K B Pryzwansky
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

8.  Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.

Authors:  M X Zhang; T R Kozel
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

9.  Systemic injection of group A streptococcal peptidoglycan-polysaccharide complexes elicits persistent neutrophilia and monocytosis associated with polyarthritis in rats.

Authors:  A F Wells; J A Hightower; C Parks; E Kufoy; A Fox
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

10.  Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury.

Authors:  R B Sartor; T M Bond; J H Schwab
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.